1WARRINGTON S,BAISLEY K,BOYCE M,et al.Effects of rabeprazole,20 mg,or esomeprazole,20 mg,on 24-h intragastric pH and serum gastrin in healthy subjects [J].Aliment Pharmacol Ther,2002,16(7):1301-1307. 被引量：1
2WILDER-SMITH C H,ROHSS K,NILSSON-PIESCHL C,et al.Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20mg in healthy volunteers[J].Digestion,2003,68(4):184-188. 被引量：1
3ANDERSSON T,ROHSS K,BREDBERG E,et al.Pharmacokinetics and pharmacodynamics of esomeprazole,the S-isomer of omeprazole[J].Aliment Pharmacol Ther,2001,15(10):1563-1569. 被引量：1
4LIND T,RYDBERG L,KYLEBACK A,et al.Esomeprazole provides improved acid control vs.omeprazole in patients with symptoms of gastro-oesophageal reflux disease [J].Aliment Pharmacol Ther,2000,14(7):861-867. 被引量：1
5THOMSON A B,KEELAN M,LASTIWKA R,et al.Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H.pylori in duodenal ulcer patients[J].Dig Dis Sci,2003,48(10):2045-2056. 被引量：1
6ROHSS K,HASSELGREN G,HEDENSTROM H.Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease[J].Dig Dis Sci,2002,47(5):954-958. 被引量：1
7LAURITSEN K,DEVIERE J,BIGARD M A,et al.Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis:metropole study results[J].Aliment Pharmacol Ther,2003,17(3):333-341. 被引量：1
4Dent J,E1-Serag H B,Walhmder M A,et al.Epidemiology of gastroesophageal reflux disease:a systematic review[J].Gut,2005,54:710-717. 被引量：1
5Lind T,Rydberg L,Kyleback A,et al.Esomeprazole provides im-proved acid control vs.omeprazole in patients with symptoms of gastro-esophageal reflux disease[J].Aliment Pharmacol Ther,2000,14(7):861-867. 被引量：1
6Koek G H,Tack J,Sifrim D,et al.The role of acid and duodenal gastroesophageal reflux in symptomatic GERD[J].Am J Gastroenterol,2001,96(7):2033-2040. 被引量：1
7Fujiwara Y, Kohata Y, Kaji M, et al. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: preva- lence, risk factors, and efficacy of rabeprazole[J]. Digestion, 2010, 81(3): 135. 被引量：1
9DeVault K R, Castell D O. Updated guidelines for the diag- nosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology[J].Am J Gastroenterol, 1999, 94 (6) : 1434. 被引量：1
10Cho Y K, Choi M G, Lim C H, et al. Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness[J ]. Stand J Gas- troenterol, 2010, 45(5): 533. 被引量：1
